Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfuzosin for Acute Urinary Retention in BPH
NCT00336921Phase 2Completed
- Sponsor
- Sanofi
- Start
- Feb 2006
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acute urinary retention comparing Alfuzosin with Placebo (2 arms). Primary endpoint: Percentage of patients with successful voiding after catheter removal at Day 4. Started Feb 2006; status: completed.
02
Drugs
alfuzosin
03
Conditions
acute urinary retention
Beyond the preview
Go deeper on NCT00336921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00336921.